EUVIMEDEUVIMED entdecken
Open Access

SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy

Alberto J Millan iD, Vincent Allain iD, Indrani Nayak iD, Jeremy B Libang, Lilian M Quijada-Madrid, Janice S Arakawa-Hoyt iD, Gabriella Ureno iD, Allison Grace Rothrock iD, Avishai Shemesh iD, Oscar A Aguilar iD, Justin Eyquem iD, Jayajit Das iD und 1 weitere

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Alberto J Millan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Syk Kinase, Killer Cells, Natural, Antigens, CD19, Immunoreceptor Tyrosine-Based Activation Motif. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells express activating receptors that signal through ITAM (immunoreceptor tyrosine-based activation motif)-bearing adapter proteins. The phosphorylation of each ITAM creates binding sites for SYK and ZAP70 protein tyrosine kinases to propagate downstream signaling including the induction of Ca2+ influx. While all immature and mature human NK cells coexpress SYK and ZAP70, clonally driven memory or adaptive NK cells can methylate SYK genes, and signaling is mediated exclusively using ZAP70. Here, we examined the role of SYK and ZAP70 in a clonal human NK cell line KHYG1 by CRISPR-based deletion using a combination of experiments and mechanistic computational modeling. Elimination of SYK resulted in more robust Ca2+ influx after crosslinking of the CD16 and NKp30 receptors and enhanced phosphorylation of downstream proteins, whereas ZAP70 deletion diminished these responses. By contrast, ZAP70 depletion increased proliferation of the NK cells. As immature T cells express both SYK and ZAP70 and mature T cells often express only ZAP70, we transduced the human Jurkat cell line with SYK and found that expression of SYK increased proliferation but diminished T cell receptor–induced Ca2+ flux and activation. We performed transcriptional analysis of the matched sets of variant Jurkat and KHYG1 cells and observed profound alterations caused by SYK expression. As depletion of SYK in NK cells increased their activation, primary human NK cells were transduced with a CD19-targeting chimeric antigen receptor and were CRISPR edited to ablate SYK or ZAP70. Deletion of SYK resulted in more robust cytotoxic activity and cytokine production, providing a new therapeutic strategy of NK cell engineering for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Syk KinaseKiller Cells, NaturalAntigens, CD19Immunoreceptor Tyrosine-Based Activation MotifImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansZAP-70 Protein-Tyrosine KinaseSignal TransductionPhosphorylation

Stichwörter der Autor:innen

Fc receptorsT cellscell activationcell surface moleculeshumannatural killer cells

Substanzen

Syk KinaseSYK protein, humanZAP-70 Protein-Tyrosine KinaseAntigens, CD19ZAP70 protein, humanReceptors, Chimeric AntigenCD19 molecule, human

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.
  • Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States.
  • Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
  • Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, United States.
  • INSERM UMR976, Hôpital Saint-Louis, Université Paris Cité, Paris, France.
  • Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States.

ORCID-Profile: Alberto J Millan, Vincent Allain, Indrani Nayak, Janice S Arakawa-Hoyt, Gabriella Ureno, Allison Grace Rothrock, Avishai Shemesh, Oscar A Aguilar, Justin Eyquem, Jayajit Das, Lewis L Lanier

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institute for General Medical Sciences
  • Parker Institute for Cancer Immunotherapy
  • Virtual Cell
  • National Institutes of Health

Zitieren

APA

Millan, A. J., Allain, V., Nayak, I., Libang, J. B., Quijada-Madrid, L. M., Arakawa-Hoyt, J. S., Ureno, G., Rothrock, A. G., Shemesh, A., Aguilar, O. A., Eyquem, J., Das, J., & Lanier, L. L. (2025). SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf012

Vancouver

Millan AJ, Allain V, Nayak I, Libang JB, Quijada-Madrid LM, Arakawa-Hoyt JS, et al. SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf012

BibTeX
@article{Millan2025,
  author = {Millan, Alberto J and Allain, Vincent and Nayak, Indrani and Libang, Jeremy B and Quijada-Madrid, Lilian M and Arakawa-Hoyt, Janice S and Ureno, Gabriella and Rothrock, Allison Grace and Shemesh, Avishai and Aguilar, Oscar A and Eyquem, Justin and Das, Jayajit and Lanier, Lewis L},
  title = {SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf012}
}
Kostenlos starten →